Your browser doesn't support javascript.
loading
Effects of a selective androgen receptor modulator (SARM), GSK2849466A, on stress urinary incontinence and bladder activity in rats with ovariectomy-induced oestrogen deficiency.
Kadekawa, Katsumi; Kawamorita, Naoki; Shimizu, Takahiro; Kurobe, Masahiro; Turnbull, Philip S; Chandra, Sundeep; Kambara, Takahito; Barton, Joanna C; Russell, Alan J; Yoshimura, Naoki.
Afiliação
  • Kadekawa K; Department of Urology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Kawamorita N; Department of Urology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Shimizu T; Department of Urology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Kurobe M; Department of Urology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Turnbull PS; Muscle Metabolism DPU, GlaxoSmithKline, King of Prussia, PA, USA.
  • Chandra S; Muscle Metabolism DPU, GlaxoSmithKline, King of Prussia, PA, USA.
  • Kambara T; Pathology, Translational Medicine & Comparative Pathobiology, GlaxoSmithKline, King of Prussia, PA, USA.
  • Barton JC; Muscle Metabolism DPU, GlaxoSmithKline, King of Prussia, PA, USA.
  • Russell AJ; Muscle Metabolism DPU, GlaxoSmithKline, King of Prussia, PA, USA.
  • Yoshimura N; Department of Urology, University of Pittsburgh, Pittsburgh, PA, USA.
BJU Int ; 125(6): 911-919, 2020 06.
Article em En | MEDLINE | ID: mdl-32011085
OBJECTIVES: To report the effect of a selective androgen receptor modulators (SARMs) on the urethral continence mechanisms in a rat model of stress urinary incontinence (SUI) induced by bilateral ovariectomy (OVX). MATERIALS AND METHODS: Female Sprague-Dawley rats with bilateral OVX were used. Rats were divided into five groups; sham operated, vehicle-treated OVX, low-dose SARM-treated OVX (GSK2849466A: 0.005 mg/kg/day, per os [p.o.]), high-dose SARM-treated OVX (GSK2849466A: 0.03 mg/kg/day, p.o.) and dihydrotestosterone (DHT)-treated OVX (1 mg/kg/day, subcutaneous) groups. After 4 weeks of SARM treatments or 3 weeks of DHT treatment (6 weeks after OVX), rats were subjected to evaluation of the sneeze-induced continence reflex using microtransducer-tipped catheter methods, sneeze-induced leak-point pressure, and continuous cystometry measurements, followed by histological analyses of urethral tissues. RESULTS: (i) OVX significantly impaired urethral continence function after 6 weeks to induce SUI during sneezing. (ii) Low-dose SARM treatment restored urethral baseline pressure (UBP) without affecting the amplitude of urethral response during sneezing (A-URS), partially reversing OVX-induced SUI during sneezing. (iii) High-dose SARM treatment reversed decreases in both UBP and A-URS, more effectively preventing SUI during sneezing. (iv) DHT treatment only restored A-URS without affecting UBP, partially preventing OVX-induced SUI during sneezing. (v) The high-dose SARM treatment induced hypertrophy of the striated and smooth muscle around the urethra. (vi) SARM treatment did not affect bladder function in sham or OVX rats. CONCLUSION: Treatment with SARMs could be a more effective modality for the treatment of SUI than DHT, without affecting bladder function, by enhancing smooth- and striated muscle-mediated urethral function under stress conditions such as sneezing.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Incontinência Urinária por Estresse / Bexiga Urinária / Ovariectomia / Antagonistas de Receptores de Andrógenos Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Incontinência Urinária por Estresse / Bexiga Urinária / Ovariectomia / Antagonistas de Receptores de Andrógenos Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article